BP000126-CYT-673: Recombinant Human Tumor Necrosis Factor Ligand Superfamily Member 1 (TNFR1) Protein, His Tag
Source: E. coli-derived.
A single, non-glycosylated, Polypeptide chain containing 161 amino acids fragment (41-201) having a molecular weight of 22.68 kDa and fused with a 4.5 kDa amino-terminal hexahistidine tag.
Purity: > 95% by SDS-PAGE.BP000126-CYT-707: Recombinant Human Tumor Necrosis Factor Ligand Superfamily Member 1 (TNFR1) Protein
Source: E. coli-derived.
A single, non-glycosylated, polypeptide chain containing 162 amino acids and having a total molecular mass of 18.2 kDa.
Purity: > 97% by SDS-PAGE and RP-HPLC.- BP000127-CYT-674: Recombinant Human Tumor Necrosis Factor Receptor Type 2 (TNFR2)
Source: E. coli-derived.
A single, non-glycosylated, Polypeptide chain containing 184 amino acids fragment (23-206) having a molecular weight of 24.45 kDa and fused with a 4.5 kDa amino-terminal hexahistidine tag.
Purity > 95%, by SDS-PAGE. PA006687-PA1842: TNFRSF10B Polyclonal Antibody
Rabbit Polyclonal Antibody;
Applications: WB, IHC-P;
Reactivity: Human;
Isotype: Rabbit IgG.BP002458-C326: Recombinant Human Tumor necrosis factor receptor superfamily member 10B (TNFRSF10B) Protein
Source: HEK 293-derived.
Purity: > 95.0% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).BP002458-CYT-069: Recombinant Human Tumor necrosis factor receptor superfamily member 10B (TNFRSF10B) Protein
Source: E. coli-derived.
The TNFRSF10B reduced the production of LPS-induced TNF by its ability to neutralize endogenous TRAIL in fresh human PBMC. In this assay, endogenous TRAIL is induced during a 24 hour exposure to LPS (10 ng/mL) but in the presence of TNFRSF10B, TRAIL-induced TNF is suppressed.
Purity: > 95.0% by SDS-PAGE.BP000106-CYT-598: Recombinant Human B-Cell Maturation Antigen
Source: E. coli-derived.
Purity > 98%, by SDS-PAGE and RP-HPLC.BP000129-C022: Recombinant Human Tumor Necrosis Factor Ligand Superfamily Member 10 (TNFSF10) Protein
Source: E. coli-derived.
The ED50 as determined by the cytolysis of murine L929 cells in the presence of Actinomycin D is less than 2 ug/ml, corresponding to a Specific Activity of 5.0 x 106 IU/mg.
Purity: > 95% by RP-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).BP000129-C326: Recombinant Human Tumor Necrosis Factor Ligand Superfamily Member 10 (TNFSF10) Protein
Source: HEK 293-derived.
Purity: > 95% by reducing SDS-PAGE and SEC-HPLC.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).BP000129-CYT-443: Recombinant Human Tumor Necrosis Factor Ligand Superfamily Member 10 (TNFSF10) Protein
Source: E. coli-derived.
The activity is determined by the cytolysis of Murine L929 cells in the presence of Actinomycin D, ED50 for this effect is less than 2 ug/ml, corresponding to a specific activity of 5,000,000 IU/mg.
Purity: > 95% by SDS-PAGE and RP-HPLC.